A RetroSearch Logo

Home - News ( United States | United Kingdom | Italy | Germany ) - Football scores

Search Query:

Showing content from https://pubmed.ncbi.nlm.nih.gov/12671061/ below:

Identification of severe acute respiratory syndrome in Canada

. 2003 May 15;348(20):1995-2005. doi: 10.1056/NEJMoa030634. Epub 2003 Mar 31. Identification of severe acute respiratory syndrome in Canada Donald E LowBonnie HenrySandy FinkelsteinDavid RoseKaren GreenRaymond TellierRyan DrakerDena AdachiMelissa AyersAdrienne K ChanDanuta M SkowronskiIrving SalitAndrew E SimorArthur S SlutskyPatrick W DoyleMel KrajdenMartin PetricRobert C BrunhamAllison J McGeerNational Microbiology Laboratory, CanadaCanadian Severe Acute Respiratory Syndrome Study Team

Affiliations

Affiliation Free article

Item in Clipboard

Identification of severe acute respiratory syndrome in Canada

Susan M Poutanen et al. N Engl J Med. 2003.

Free article . 2003 May 15;348(20):1995-2005. doi: 10.1056/NEJMoa030634. Epub 2003 Mar 31. Authors Susan M Poutanen  1 Donald E LowBonnie HenrySandy FinkelsteinDavid RoseKaren GreenRaymond TellierRyan DrakerDena AdachiMelissa AyersAdrienne K ChanDanuta M SkowronskiIrving SalitAndrew E SimorArthur S SlutskyPatrick W DoyleMel KrajdenMartin PetricRobert C BrunhamAllison J McGeerNational Microbiology Laboratory, CanadaCanadian Severe Acute Respiratory Syndrome Study Team Affiliation

Item in Clipboard

Abstract

Background: Severe acute respiratory syndrome (SARS) is a condition of unknown cause that has recently been recognized in patients in Asia, North America, and Europe. This report summarizes the initial epidemiologic findings, clinical description, and diagnostic findings that followed the identification of SARS in Canada.

Methods: SARS was first identified in Canada in early March 2003. We collected epidemiologic, clinical, and diagnostic data from each of the first 10 cases prospectively as they were identified. Specimens from all cases were sent to local, provincial, national, and international laboratories for studies to identify an etiologic agent.

Results: The patients ranged from 24 to 78 years old; 60 percent were men. Transmission occurred only after close contact. The most common presenting symptoms were fever (in 100 percent of cases) and malaise (in 70 percent), followed by nonproductive cough (in 100 percent) and dyspnea (in 80 percent) associated with infiltrates on chest radiography (in 100 percent). Lymphopenia (in 89 percent of those for whom data were available), elevated lactate dehydrogenase levels (in 80 percent), elevated aspartate aminotransferase levels (in 78 percent), and elevated creatinine kinase levels (in 56 percent) were common. Empirical therapy most commonly included antibiotics, oseltamivir, and intravenous ribavirin. Mechanical ventilation was required in five patients. Three patients died, and five have had clinical improvement. The results of laboratory investigations were negative or not clinically significant except for the amplification of human metapneumovirus from respiratory specimens from five of nine patients and the isolation and amplification of a novel coronavirus from five of nine patients. In four cases both pathogens were isolated.

Conclusions: SARS is a condition associated with substantial morbidity and mortality. It appears to be of viral origin, with patterns suggesting droplet or contact transmission. The role of human metapneumovirus, a novel coronavirus, or both requires further investigation.

Copyright 2003 Massachusetts Medical Society

PubMed Disclaimer

Comment in Similar articles Cited by

RetroSearch is an open source project built by @garambo | Open a GitHub Issue

Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo

HTML: 3.2 | Encoding: UTF-8 | Version: 0.7.3